Preprint · CC-BY
via bioRxiv
Characterizing massa intermedia morphology in schizophrenia: associations with aging, neuropsychological functioning, and atypical hippocampal development
Bergson, Z., Roeske, M. J., Rogers, B. P., Huang, A. S., Fox, V., Heckers, S., Woodward, N. D.
biorxiv · 2025
Abstract
The massa intermedia (MI) is a midline structure connecting the left and right thalamus that typically develops during the 2nd trimester of pregnancy. Missing and smaller MI has been linked to neurodevelopmental disorders, including schizophrenia (SZ), and subtle deficits in cognition. However, findings are inconsistent and the association between MI and other anatomical variants linked to atypical brain development in SZ, including incomplete hippocampal inversion (IHI), is unclear. Presence/absence and morphology of the MI were ascertained on structural T1-weighted MRI images obtained at 3T in SZ (n = 223) and healthy individuals (n = 194) and compared between groups. Associations between MI morphology, cognitive function, and incomplete hippocampal inversion (IHI) were assessed. Prevalence of missing MI was 1.7% and did not differ between groups. MI was significantly smaller in SZ (p <.001). However, follow-up analyses revealed that smaller MI size in SZ was due to a significant Diagnosis x Age interaction characterized by a stronger negative age effect in SZ. IHI was significantly more common in individuals with missing MI. Neurocognition was not correlated with MI size when controlling for age and diagnosis. Stronger effects of age on MI size in SZ suggests that abnormal MI size measured in adulthood may not be a reliable static indicator of atypical neurodevelopment, but may reflect disease progression or accelerated aging. Missing MI was rare in our sample. Conversely, missing MI is associated with IHI suggesting a shared neurodevelopmental disruption in the 2nd trimester.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- bioRxiv
- DOI
- 10.1101/2025.02.26.640398
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
Z., B., J., R.M., P., R.B., S., H.A., V., F., S., H., & D., W.N. (2025). Characterizing massa intermedia morphology in schizophrenia: associations with aging, neuropsychological functioning, and atypical hippocampal development. <em>biorxiv</em>. https://doi.org/10.1101/2025.02.26.640398
Vancouver
Z. B, J. RM, P. RB, S. HA, V. F, S. H, et al. Characterizing massa intermedia morphology in schizophrenia: associations with aging, neuropsychological functioning, and atypical hippocampal development. biorxiv. 2025. doi:10.1101/2025.02.26.640398.
BibTeX
@unpublished{bergson2025Charac,
title = {Characterizing massa intermedia morphology in schizophrenia: associations with aging, neuropsychological functioning, and atypical hippocampal development},
author = {Bergson, Z. and Roeske, M. J. and Rogers, B. P. and Huang, A. S. and Fox, V. and Heckers, S. and Woodward, N. D.},
journal = {biorxiv},
year = {2025},
doi = {10.1101/2025.02.26.640398},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The Journals of Gerontology Series A 2020
Open access · CC-BY
Short Leukocyte Telomeres, But Not Telomere Attrition Rates, Predict Memory Decline in the 20-Year Longitudinal Betula Study
The International Journal of Neuropsychopharmacology 2018
Open access · CC-BY
Repeated Systemic Treatment with Rapamycin Affects Behavior and Amygdala Protein Expression in Rats
Brain Behavior and Immunity 2026
Open access · CC-BY
Inflammatory markers (IL-6 and CRP) in childhood and their association with brain structure and psychotic experiences in adulthood
Stanford University 2009
Open access · US-GOV
U19 Influenza Immunity: Protective Mechanisms Against a Pandemic Respiratory Virus. Project 1: B-cell Immunity to Influenza. Technical Development Project 1: Measuring the Immunome: Genomic Approaches to B-cell Repertoire- Year 1, 2009
eLife 2026
Preprint · CC-BY
A translational transcriptomic signature of vaccine reactogenicity for the evaluation of novel formulations
eLife 2026
Preprint · CC-BY